Bicycle Therapeutics (BCYC) Operating Income (2018 - 2025)
Historic Operating Income for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$65.6 million.
- Bicycle Therapeutics' Operating Income fell 267.05% to -$65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$290.0 million, marking a year-over-year decrease of 4763.49%. This contributed to the annual value of -$209.9 million for FY2024, which is 1049.03% down from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Operating Income is -$65.6 million, which was down 267.05% from -$86.6 million recorded in Q2 2025.
- Bicycle Therapeutics' Operating Income's 5-year high stood at -$14.3 million during Q3 2021, with a 5-year trough of -$86.6 million in Q2 2025.
- In the last 5 years, Bicycle Therapeutics' Operating Income had a median value of -$41.8 million in 2023 and averaged -$42.3 million.
- Its Operating Income has fluctuated over the past 5 years, first skyrocketed by 2412.98% in 2024, then plummeted by 12135.2% in 2025.
- Bicycle Therapeutics' Operating Income (Quarter) stood at -$18.0 million in 2021, then crashed by 78.71% to -$32.2 million in 2022, then tumbled by 68.37% to -$54.2 million in 2023, then decreased by 24.76% to -$67.7 million in 2024, then grew by 3.12% to -$65.6 million in 2025.
- Its Operating Income was -$65.6 million in Q3 2025, compared to -$86.6 million in Q2 2025 and -$70.2 million in Q1 2025.